Merit Medical Reports Record Revenues for Second Quarter of 2018; Merit Adjusts 2018 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Merit Medical Systems, Inc. (MMSI) PT Raised to $67 at Needham & Company
July 24, 2018 6:31 AM EDTNeedham & Company raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $67.00 (from $54.00) while maintaining a Buy rating.
Analsyt Mike Matson commented, "MMSI's 2Q18 revenue and EPS beat consensus. Management raised its 2018 revenue and EPS guidance but lowered its 2018 gross margin... More
Merit Medical Systems (MMSI) Tops Q2 EPS by 3c; Raises Outlook
July 23, 2018 4:04 PM EDTMerit Medical Systems (NASDAQ: MMSI) reported Q2 EPS of $0.43, $0.03 better than the analyst estimate of $0.40. Revenue for the quarter came in at $224.8 million versus the consensus estimate of $214.63 million.
GUIDANCE:
Merit Medical Systems sees FY2018 EPS of $1.60-$1.70, versus... More
